Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-term Effectiveness and Immuno-persistence Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Girls Aged 9-17 Years

NCT06243666 is registered in ClinicalTrials.gov with Xiamen University as lead sponsor.

NCT NCT06243666
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06243666 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-term Effectiveness and Immuno-persistence Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Girls Aged 9-17 Years
Lead sponsor
Xiamen University
Phase
Observational
Overall status
Active, not recruiting
Start date
February 20, 2024
Completion date
December 31, 2026
Enrollment
2,188 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer, cervical intraepithelial neoplasia, persistent infection